Comparative analysis of the cost and carbon footprint of acne treatments in the NHS
This study considers the carbon footprint of diverse acne vulgaris pharmaceutical treatments modelled on a 6-month course of monotherapy and treatment-related processes.
Authors
- Yasmin Nikookam (ORCID: https://orcid.org/0000-0003-2069-0486)
- Rachel Abbott (ORCID: https://orcid.org/0000-0002-3415-7132)
- Sangeeta Punjabi
- Simon Tso (ORCID: https://orcid.org/0000-0001-9221-7618)
- Sarika Grover
- David de Berker (ORCID: https://orcid.org/0009-0005-4699-261X)
- William Hunt
- Tamara Griffiths (ORCID: https://orcid.org/0000-0002-2558-2954)
Institutions
- George Eliot Hospital (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- University Hospital of Wales (GB)
- University of Manchester (GB)
- University Hospital Regensburg (DE)
- Northern Health and Social Care Trust (GB)
- British Association of Dermatologists (GB)
- George Eliot Hospital NHS Trust (GB)
- University Dermatology (US)
- South Warwickshire NHS Foundation Trust (GB)
- University Hospitals Plymouth NHS Trust (GB)
- Cardiff University (GB)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1093/ced/llaf258
- Citations
- 1
- Primary Topic
- Acne and Rosacea Treatments and Effects
- Type
- article
- Field-Weighted Citation Impact
- 2.00